Works about CHALONES

Results: 373
    1

    Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf138
    By:
    • Beckermann, Kathryn E;
    • Shah, Neil J;
    • Campbell, Matthew T;
    • Haas, Naomi B;
    • Nelson, Ariel;
    • Ornstein, Moshe C;
    • Mao, Shifeng;
    • Keshava-Prasad, Holavanahalli S;
    • Hammers, Hans;
    • Gao, Xin;
    • Gourdin, Theodore;
    • George, Saby;
    • Hoimes, Christopher J;
    • Hussain, Arif;
    • Jonasch, Eric;
    • Rini, Brian I;
    • Voss, Martin H
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. 818, doi. 10.1002/onco.13880
    By:
    • Mortensen, Lindsey;
    • Ordulu, Zehra;
    • Dagogo‐Jack, Ibiayi;
    • Bossuyt, Veerle;
    • Winters, Loren;
    • Taghian, Alphonse;
    • Smith, Barbara L.;
    • Ellisen, Leif W.;
    • Kiedrowski, Lesli A.;
    • Lennerz, Jochen K.;
    • Bardia, Aditya;
    • Spring, Laura M.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50